Current therapeutic strategies include avoidance, which is unreliable, and unspecific symptom management, which causes adverse effects and are expensive
Consult a healthcare provider before starting peptides, especially if you have medical conditions or take medications
Interestingly, the GLP-1 receptor agonist, dulaglutide, and the dual GLP-1 and GIP receptor agonist, tirzepatide, are both characterized by a strong delayed gastric emptying upon a single dose administration, but the effect tends to subside as gastric emptying tachyphylaxis is observed after several weeks of treatment
Recent results from the DARE-ESKD Phase 1 trial (NCT05343078), on Pharmacokinetics and Dialyzability of Dapagliflozin in Dialysis Patients including a total of 7 patients (2 on peritoneal dialysis) have shown that dapagliflozin was well tolerated, slightly dialyzable, and had non-accumulating pharmacokinetic properties35 (Table 2)
The first time I tried to run after pushing that heavy sled was a revealing moment...jello legs are a real thing
Providers remain available for follow-ups and dose adjustments, helping you stay on track safely and effectively
